{"database":"biostudies-literature","file_versions":[],"scores":{"citationCount":0,"reanalysisCount":0,"viewCount":76,"searchCount":0},"additional":{"submitter":["Norris PC"],"funding":["NIGMS NIH HHS"],"pagination":["8517-22"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3365225"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["109(22)"],"pubmed_abstract":["Dietary fish oil containing ?3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), elicit cardioprotective and anti-inflammatory effects through unresolved mechanisms that may involve competition and inhibition at multiple levels. Here, we report the effects of arachidonic acid (AA), EPA, and DHA supplementation on membrane incorporation, phospholipase A(2) catalyzed release, and eicosanoid production in RAW264.7 macrophages. Using a targeted lipidomics approach, we observed that Toll-like receptor 4 and purinergic receptor activation of supplemented cells leads to the release of 22-carbon fatty acids that potently inhibit cyclooxygenase pathways. This inhibition was able to shunt metabolism of AA to lipoxygenase pathways, augmenting leukotriene and other lipoxygenase mediator synthesis. In resident peritoneal macrophages, docosapentaenoic acid (DPA) was responsible for cyclooxygenase inhibition after EPA supplementation, offering fresh insights into how EPA exerts anti-inflammatory effects indirectly through elongation to 22-carbon DPA."],"journal":["Proceedings of the National Academy of Sciences of the United States of America"],"pubmed_title":["Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling."],"pmcid":["PMC3365225"],"funding_grant_id":["R01 GM64611","R01 GM064611","T32 GM007752","U54 GM069338"],"pubmed_authors":["Dennis EA","Norris PC"],"view_count":["76"],"additional_accession":[]},"is_claimable":false,"name":"Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling.","description":"Dietary fish oil containing ?3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), elicit cardioprotective and anti-inflammatory effects through unresolved mechanisms that may involve competition and inhibition at multiple levels. Here, we report the effects of arachidonic acid (AA), EPA, and DHA supplementation on membrane incorporation, phospholipase A(2) catalyzed release, and eicosanoid production in RAW264.7 macrophages. Using a targeted lipidomics approach, we observed that Toll-like receptor 4 and purinergic receptor activation of supplemented cells leads to the release of 22-carbon fatty acids that potently inhibit cyclooxygenase pathways. This inhibition was able to shunt metabolism of AA to lipoxygenase pathways, augmenting leukotriene and other lipoxygenase mediator synthesis. In resident peritoneal macrophages, docosapentaenoic acid (DPA) was responsible for cyclooxygenase inhibition after EPA supplementation, offering fresh insights into how EPA exerts anti-inflammatory effects indirectly through elongation to 22-carbon DPA.","dates":{"release":"2012-01-01T00:00:00Z","publication":"2012 May","modification":"2021-02-20T20:36:56Z","creation":"2019-03-27T00:54:02Z"},"accession":"S-EPMC3365225","cross_references":{"pubmed":["22586114"],"doi":["10.1073/pnas.1200189109"]}}